BioOss
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $92,385 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $92,385 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A 4-arm randomized controlled trial of wound healing following tooth extraction and ridge preservation using DFDBA alone in particulate or fiber form, and in combinations with xenograft | Geistlich Pharma, North America, Inc. | $92,385 | 0 |
Top Doctors Receiving Payments for BioOss
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Antonio, TX | $92,385 | 1 |
Manufacturing Companies
Product Information
- Type Device
- Total Payments $92,385
- Total Doctors 0
- Transactions 1
About BioOss
BioOss is a device associated with $92,385 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Geistlich Pharma, North America, Inc..
Payment data is available from 2022 to 2022. In 2022, $92,385 was paid across 1 transactions to 0 doctors.
The most common payment nature for BioOss is "Unspecified" ($92,385, 100.0% of total).
BioOss is associated with 1 research study, including "A 4-arm randomized controlled trial of wound healing following tooth extraction and ridge preservation using DFDBA alone in particulate or fiber form, and in combinations with xenograft" ($92,385).